Clinical trial · Observational
3D Structural Imaging of Human Breast Tissues
NCT06454214CI-TRIAL-00078281not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project aims to develop an advanced ex vivo medical microscopic imaging technology. By developing breast tissue staining techniques, acquiring microscopic images, and performing structural reconstruction, we seek to observe the 3D structure of breast tissue. This includes examining cell distribution, mammary ducts, and blood vessel distribution, to explore the different biological characteristics between normal breast tissue and various types of cancerous tissues.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Human Breast Tissues | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Multi-photon microscopy | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Control breast tissues (normal breast tissues)
- description
- Normal tissue contained within the surgically excised specimen
- interventionNames
- Device: Multi-photon microscopy
- label
- Cancerous breast tissues
- description
- Tumor tissue contained within the surgically excised specimen
- interventionNames
- Device: Multi-photon microscopy
Primary outcomes (1)
- measure
- Accuracy dependency on staining dye selection
- timeFrame
- 3 years
- description
- Using other types of staining agents, compare the diagnostic accuracy of the results with those of traditional pathological staining agents.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adults aged 18 and above. * Patients clinically diagnosed with breast cancer. Exclusion Criteria: * Patients unable to provide consent (e.g., inability to speak, inability to communicate in Chinese, etc.). * Patients for whom a definitive pathological diagnosis cannot be established. * Patients suitable only for biopsy and not for surgical excision. * Excised tissue showing severe radiation-induced changes under pathological examination. * Tumor specimens smaller than 1 cm. * Patients with ductal carcinoma in situ (DCIS).
References
Publications (0)
Data not yet available
No reference posted for this study.